Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 349

1.

Progress toward eliminating TB and HIV deaths in Brazil, 2001-2015: a spatial assessment.

Ross JM, Henry NJ, Dwyer-Lindgren LA, de Paula Lobo A, Marinho de Souza F, Biehl MH, Ray SE, Reiner RC Jr, Stubbs RW, Wiens KE, Earl L, Kutz MJ, Bhattacharjee NV, Kyu HH, Naghavi M, Hay SI.

BMC Med. 2018 Sep 6;16(1):144. doi: 10.1186/s12916-018-1131-6.

2.

Frey's syndrome following a facial burn treated with botulinum toxin.

Henry N, Baker BG, Iyer S.

Ann Burns Fire Disasters. 2018 Mar 31;31(1):47-48.

3.

Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927).

Shen S, Unger JM, Crew KD, Till C, Greenlee H, Gralow J, Dakhil SR, Minasian LM, Wade JL 3rd, Fisch MJ, Henry NL, Hershman DL.

Breast Cancer Res Treat. 2018 Aug 29. doi: 10.1007/s10549-018-4946-0. [Epub ahead of print]

PMID:
30159789
4.

Unilateral Phrenic Nerve Palsy in Infants with Congenital Zika Syndrome.

Rajapakse NS, Ellsworth K, Liesman RM, Ho ML, Henry N, Theel ES, Wallace A, Alvino ACI, Medeiros de Mello L, Meneses J.

Emerg Infect Dis. 2018 Aug;24(8). doi: 10.3201/eid2408.180057.

5.

Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.

Hershman DL, Unger JM, Greenlee H, Capodice JL, Lew DL, Darke AK, Kengla AT, Melnik MK, Jorgensen CW, Kreisle WH, Minasian LM, Fisch MJ, Henry NL, Crew KD.

JAMA. 2018 Jul 10;320(2):167-176. doi: 10.1001/jama.2018.8907.

PMID:
29998338
6.

The inducible chemical-genetic fluorescent marker FAST outperforms classical fluorescent proteins in the quantitative reporting of bacterial biofilm dynamics.

Monmeyran A, Thomen P, Jonquière H, Sureau F, Li C, Plamont MA, Douarche C, Casella JF, Gautier A, Henry N.

Sci Rep. 2018 Jul 9;8(1):10336. doi: 10.1038/s41598-018-28643-z.

7.

Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy.

Sun Y, Kim JH, Vangipuram K, Hayes DF, Smith EML, Yeomans L, Henry NL, Stringer KA, Hertz DL.

Breast Cancer Res Treat. 2018 Oct;171(3):657-666. doi: 10.1007/s10549-018-4862-3. Epub 2018 Jun 26.

PMID:
29946863
8.

Formation of a new type of uranium(iv) poly-oxo cluster {U38} based on a controlled release of water via esterification reaction.

Martin NP, Volkringer C, Henry N, Trivelli X, Stoclet G, Ikeda-Ohno A, Loiseau T.

Chem Sci. 2018 May 9;9(22):5021-5032. doi: 10.1039/c8sc00752g. eCollection 2018 Jun 14.

9.

Lipidated apolipoprotein E4 structure and its receptor binding mechanism determined by a combined cross-linking coupled to mass spectrometry and molecular dynamics approach.

Henry N, Krammer EM, Stengel F, Adams Q, Van Liefferinge F, Hubin E, Chaves R, Efremov R, Aebersold R, Vandenbussche G, Prévost M, Raussens V, Deroo S.

PLoS Comput Biol. 2018 Jun 22;14(6):e1006165. doi: 10.1371/journal.pcbi.1006165. eCollection 2018 Jun.

10.

Temporal characteristics of quantum cascade laser frequency modulated combs in long wave infrared and THz regions.

Henry N, Burghoff D, Hu Q, Khurgin JB.

Opt Express. 2018 May 28;26(11):14201-14212. doi: 10.1364/OE.26.014201.

PMID:
29877461
11.

Synthesis and structural characterization of the first neptunium based metal-organic frameworks incorporating {Np6O8} hexanuclear clusters.

Martin NP, März J, Feuchter H, Duval S, Roussel P, Henry N, Ikeda-Ohno A, Loiseau T, Volkringer C.

Chem Commun (Camb). 2018 Jun 21;54(51):6979-6982. doi: 10.1039/c8cc03121e.

PMID:
29796494
12.

The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.

Caughran J, Braun TM, Breslin TM, Smith DR, Kreinbrink JL, Parish GK, Davis AT, Bacon-Baguley TA, Silver SM, Henry NL.

Breast J. 2018 Sep;24(5):730-737. doi: 10.1111/tbj.13034. Epub 2018 May 21.

PMID:
29785764
13.

Intermittent Pili-Mediated Forces Fluidize Neisseria meningitidis Aggregates Promoting Vascular Colonization.

Bonazzi D, Lo Schiavo V, Machata S, Djafer-Cherif I, Nivoit P, Manriquez V, Tanimoto H, Husson J, Henry N, Chaté H, Voituriez R, Duménil G.

Cell. 2018 Jun 28;174(1):143-155.e16. doi: 10.1016/j.cell.2018.04.010. Epub 2018 May 17.

PMID:
29779947
14.

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial.

Santa-Maria CA, Bardia A, Blackford AL, Snyder C, Connolly RM, Fetting JH, Hayes DF, Jeter SC, Miller RS, Nguyen A, Quinlan K, Rosner GL, Slater S, Storniolo AM, Wolff AC, Zorzi J, Henry NL, Stearns V.

Breast Cancer Res Treat. 2018 May 11. doi: 10.1007/s10549-018-4811-1. [Epub ahead of print]

PMID:
29752687
15.

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy.

Hertz DL, Kidwell KM, Vangipuram K, Li F, Pai MP, Burness M, Griggs JJ, Schott AF, Van Poznak C, Hayes DF, Lavoie Smith EM, Henry NL.

Clin Cancer Res. 2018 Aug 1;24(15):3602-3610. doi: 10.1158/1078-0432.CCR-18-0656. Epub 2018 Apr 27.

PMID:
29703818
16.

Measuring Quality of Care in Community Mental Health: Validation of Concordant Clinician and Client Quality-of-Care Scales.

Luther L, Fukui S, Garabrant JM, Rollins AL, Morse G, Henry N, Shimp D, Gearhart T, Salyers MP.

J Behav Health Serv Res. 2018 Apr 12. doi: 10.1007/s11414-018-9601-3. [Epub ahead of print]

PMID:
29651600
17.

The Initial Impact of Tele-Critical Care on the Surgical Services of a Community Military Hospital.

Van Gent JM, Davis KL, Henry N, Zander AL, Kuettel MA, Edson T, Nelson TJ, Tadlock MD.

Mil Med. 2018 Apr 4. doi: 10.1093/milmed/usy051. [Epub ahead of print]

PMID:
29635539
18.

Disparities in cancer survival and incidence by metropolitan versus rural residence in Utah.

Hashibe M, Kirchhoff AC, Kepka D, Kim J, Millar M, Sweeney C, Herget K, Monroe M, Henry NL, Lopez AM, Mooney K.

Cancer Med. 2018 Apr;7(4):1490-1497. doi: 10.1002/cam4.1382. Epub 2018 Mar 13.

19.

Mapping child growth failure in Africa between 2000 and 2015.

Osgood-Zimmerman A, Millear AI, Stubbs RW, Shields C, Pickering BV, Earl L, Graetz N, Kinyoki DK, Ray SE, Bhatt S, Browne AJ, Burstein R, Cameron E, Casey DC, Deshpande A, Fullman N, Gething PW, Gibson HS, Henry NJ, Herrero M, Krause LK, Letourneau ID, Levine AJ, Liu PY, Longbottom J, Mayala BK, Mosser JF, Noor AM, Pigott DM, Piwoz EG, Rao P, Rawat R, Reiner RC, Smith DL, Weiss DJ, Wiens KE, Mokdad AH, Lim SS, Murray CJL, Kassebaum NJ, Hay SI.

Nature. 2018 Feb 28;555(7694):41-47. doi: 10.1038/nature25760.

20.

Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer.

Bhave MA, Speth KA, Kidwell KM, Lyden A, Alsamarraie C, Murphy SL, Henry NL.

Clin Breast Cancer. 2018 Apr;18(2):168-174.e2. doi: 10.1016/j.clbc.2017.12.012. Epub 2017 Dec 27.

PMID:
29361424
21.

Labyrinthine Sequestrum: A Case Report and Review of the Literature.

Guerin JB, Vork DL, Eguiguren L, Marston AP, Driscoll CLW, Carlson ML, Henry NK, Lane JI.

Otol Neurotol. 2018 Mar;39(3):340-343. doi: 10.1097/MAO.0000000000001676.

PMID:
29337715
22.

Managing physical and mental health conditions: Consumer perspectives on integrated care.

Rollins AL, Wright-Berryman J, Henry NH, Quash AM, Benbow K, Bonfils KA, Hedrick H, Miller AP, Firmin R, Salyers MP.

Soc Work Ment Health. 2017;15(1):66-79. doi: 10.1080/15332985.2016.1173160. Epub 2016 May 13.

23.

Residual symptoms and disease burden among patients with rheumatoid arthritis in remission or low disease activity: a systematic literature review.

Ishida M, Kuroiwa Y, Yoshida E, Sato M, Krupa D, Henry N, Ikeda K, Kaneko Y.

Mod Rheumatol. 2018 Sep;28(5):789-799. doi: 10.1080/14397595.2017.1416940. Epub 2018 Jan 11.

PMID:
29251034
24.

New extension software modules to enhance searching and display of transcriptome data in Tripal databases.

Chen M, Henry N, Almsaeed A, Zhou X, Wegrzyn J, Ficklin S, Staton M.

Database (Oxford). 2017 Jan 1;2017. doi: 10.1093/database/bax052.

25.

Attempted replication of SNPs in RANKL and OPG with musculoskeletal adverse events during aromatase inhibitor treatment for breast cancer.

Dempsey JM, Xi J, Henry NL, Rae JM, Hertz DL.

Physiol Genomics. 2018 Feb 1;50(2):98-99. doi: 10.1152/physiolgenomics.00085.2017. Epub 2017 Dec 8.

26.

Innovative strategies for intervertebral disc regenerative medicine: From cell therapies to multiscale delivery systems.

Henry N, Clouet J, Le Bideau J, Le Visage C, Guicheux J.

Biotechnol Adv. 2018 Jan - Feb;36(1):281-294. doi: 10.1016/j.biotechadv.2017.11.009. Epub 2017 Dec 1. Review.

PMID:
29199133
27.

Integrating clinicopathologic and genomic tools in chemotherapy decision-making for early stage breast cancer.

Havard R, Henry NL.

Future Oncol. 2017 Dec;13(28):2507-2510. doi: 10.2217/fon-2017-0452. Epub 2017 Nov 23. No abstract available.

PMID:
29168654
28.

Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden.

Henry N, Jovanović J, Schlueter M, Kritikou P, Wilson K, Myrén KJ.

J Med Econ. 2018 Apr;21(4):318-325. doi: 10.1080/13696998.2017.1405816. Epub 2017 Dec 4.

PMID:
29139314
29.

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202.

Henry NL, Unger JM, Schott AF, Fehrenbacher L, Flynn PJ, Prow DM, Sharer CW, Burton GV, Kuzma CS, Moseley A, Lew DL, Fisch MJ, Moinpour CM, Hershman DL, Wade JL 3rd.

J Clin Oncol. 2018 Feb 1;36(4):326-332. doi: 10.1200/JCO.2017.74.6651. Epub 2017 Nov 14.

30.

Successful Implementation of Low-Cost Tele-Critical Care Solution by the U.S. Navy: Initial Experience and Recommendations.

Davis K, Perry-Moseanko A, Tadlock MD, Henry N, Pamplin J.

Mil Med. 2017 May;182(5):e1702-e1707. doi: 10.7205/MILMED-D-16-00277.

PMID:
29087914
31.

INTERACT in VA Community Living Centers (CLCs): Training and Implementation Strategies.

Mochel AL, Henry ND, Saliba D, Phibbs CS, Ouslander JG, Mor V.

Geriatr Nurs. 2018 Mar - Apr;39(2):212-218. doi: 10.1016/j.gerinurse.2017.09.002. Epub 2017 Oct 5.

PMID:
28988835
33.

Pullulan microbeads/Si-HPMC hydrogel injectable system for the sustained delivery of GDF-5 and TGF-β1: new insight into intervertebral disc regenerative medicine.

Henry N, Clouet J, Fragale A, Griveau L, Chédeville C, Véziers J, Weiss P, Le Bideau J, Guicheux J, Le Visage C.

Drug Deliv. 2017 Nov;24(1):999-1010. doi: 10.1080/10717544.2017.1340362.

PMID:
28645219
34.

Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients.

Hertz DL, Speth KA, Kidwell KM, Gersch CL, Desta Z, Storniolo AM, Stearns V, Skaar TC, Hayes DF, Henry NL, Rae JM.

Breast Cancer Res Treat. 2017 Oct;165(3):659-668. doi: 10.1007/s10549-017-4346-x. Epub 2017 Jun 22.

PMID:
28643023
35.

Standard and Genomic Tools for Decision Support in Breast Cancer Treatment.

Henry NL, Bedard PL, DeMichele A.

Am Soc Clin Oncol Educ Book. 2017;37:106-115. doi: 10.14694/EDBK_175617. Review.

36.

Cationic polycyclization of ynamides: building up molecular complexity.

Theunissen C, Métayer B, Lecomte M, Henry N, Chan HC, Compain G, Gérard P, Bachmann C, Mokhtari N, Marrot J, Martin-Mingot A, Thibaudeau S, Evano G.

Org Biomol Chem. 2017 May 23;15(20):4399-4416. doi: 10.1039/c7ob00850c.

PMID:
28485455
37.

Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors.

Kadakia KC, Kidwell KM, Seewald NJ, Snyder CF, Storniolo AM, Otte JL, Flockhart DA, Hayes DF, Stearns V, Henry NL.

Breast Cancer Res Treat. 2017 Jul;164(2):411-419. doi: 10.1007/s10549-017-4260-2. Epub 2017 Apr 27.

38.

Bacterial biofilm under flow: First a physical struggle to stay, then a matter of breathing.

Thomen P, Robert J, Monmeyran A, Bitbol AF, Douarche C, Henry N.

PLoS One. 2017 Apr 12;12(4):e0175197. doi: 10.1371/journal.pone.0175197. eCollection 2017.

39.

Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation.

Henry NL, Speth K, Lintermans A, Kidwell KM, Carlson R, Hayes DF, Neven P.

Clin Breast Cancer. 2017 Aug;17(5):350-355.e4. doi: 10.1016/j.clbc.2017.03.002. Epub 2017 Mar 11.

40.

Germline genetic predictors of aromatase inhibitor concentrations, estrogen suppression and drug efficacy and toxicity in breast cancer patients.

Hertz DL, Henry NL, Rae JM.

Pharmacogenomics. 2017 Apr;18(5):481-499. doi: 10.2217/pgs-2016-0205. Epub 2017 Mar 27. Review.

PMID:
28346074
41.

Variation in the use of advanced imaging at the time of breast cancer diagnosis in a statewide registry.

Henry NL, Braun TM, Breslin TM, Gorski DH, Silver SM, Griggs JJ.

Cancer. 2017 Aug 1;123(15):2975-2983. doi: 10.1002/cncr.30674. Epub 2017 Mar 16.

42.

A 15-month-old With Fever and Malaise.

Stetson R, Anderson JH, Henry NK.

Pediatr Infect Dis J. 2017 Apr;36(4):438. doi: 10.1097/INF.0000000000001468. No abstract available.

PMID:
28288082
43.

Extended Endocrine Therapy: Is 5 Years Enough?

Bhave MA, Henry NL.

Curr Oncol Rep. 2017 Mar;19(3):16. doi: 10.1007/s11912-017-0576-7. Review.

PMID:
28251491
44.

Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer.

Salgado TM, Davis EJ, Farris KB, Fawaz S, Batra P, Henry NL.

Breast Cancer Res Treat. 2017 Jun;163(2):311-319. doi: 10.1007/s10549-017-4177-9. Epub 2017 Mar 1.

PMID:
28251384
45.

Synthesis of Coordination Polymers of Tetravalent Actinides (Uranium and Neptunium) with a Phthalate or Mellitate Ligand in an Aqueous Medium.

Martin NP, März J, Volkringer C, Henry N, Hennig C, Ikeda-Ohno A, Loiseau T.

Inorg Chem. 2017 Mar 6;56(5):2902-2913. doi: 10.1021/acs.inorgchem.6b02962. Epub 2017 Feb 16.

PMID:
28205439
46.

Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer.

Robarge JD, Desta Z, Nguyen AT, Li L, Hertz D, Rae JM, Hayes DF, Storniolo AM, Stearns V, Flockhart DA, Skaar TC, Henry NL.

Breast Cancer Res Treat. 2017 Feb;161(3):453-461. doi: 10.1007/s10549-016-4077-4. Epub 2016 Dec 9.

47.

Associations between use of the 21-gene recurrence score assay and chemotherapy regimen selection in a statewide registry.

Henry NL, Braun TM, Ali HY, Munir K, Silver SM, Gorski DH, Breslin TM, Griggs JJ.

Cancer. 2017 May 15;123(6):948-956. doi: 10.1002/cncr.30429. Epub 2016 Oct 27.

48.

Developing a Hypnotic Relaxation Intervention to Improve Body Image: A Feasibility Study.

Cieslak A, Elkins G, Banerjee T, Marsack J, Hickman K, Johnson A, Henry N, Barton D.

Oncol Nurs Forum. 2016 Nov 1;43(6):E233-E241.

PMID:
27768128
49.

Underlying Mechanisms of Protection Involved in Immunocloak.

Brasile L, Henry N, Stubenitsky B.

Transplantation. 2017 Feb;101(2):e49-e56. doi: 10.1097/TP.0000000000001537.

50.

Impact of neoadjuvant therapy on eligibility for and frequency of breast conservation in stage II-III HER2-positive breast cancer: surgical results of CALGB 40601 (Alliance).

Golshan M, Cirrincione CT, Sikov WM, Carey LA, Berry DA, Overmoyer B, Henry NL, Somlo G, Port E, Burstein HJ, Hudis C, Winer E, Ollila DW; Alliance for Clinical Trials in Oncology.

Breast Cancer Res Treat. 2016 Nov;160(2):297-304. Epub 2016 Oct 4.

Supplemental Content

Support Center